Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection

Patients with anti–IFN-γ autoantibodies have impaired IFN-γ signaling, leading to severe disseminated infections with intracellular pathogens, especially nontuberculous mycobacteria. Disease may be severe and progressive, despite aggressive treatment. To address the underlying pathogenic IFN-γ autoa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Browne, Sarah K., Zaman, Rifat, Sampaio, Elizabeth P., Jutivorakool, Kamonwan, Rosen, Lindsey B., Ding, Li, Pancholi, Minjal J., Yang, Lauren M., Priel, Debra Long, Uzel, Gulbu, Freeman, Alexandra F., Hayes, Carlton E., Baxter, Roger, Cohen, Stuart H., Holland, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350360/
https://ncbi.nlm.nih.gov/pubmed/22403254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-395707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados